| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. S1CDEF
Kulkarni SS et al. (2024)
|
Xtr Wt + cfap53 MO
NF27-29/30 (in situ hybridization)
|
|
visceral heterotaxy
|
|
Fig. 2 b c
Lee H et al. (2024)
|
Xla Wt + rspo2 left + Methyl cellulose
NF19 (in situ hybridization)
|
|
|
|
Fig. 1 op
Lee H et al. (2024)
|
Xla Wt + rspo2 MO - left
NF31 (in situ hybridization)
|
|
visceral heterotaxy
|
|
|
Fig. 1 op
Lee H et al. (2024)
|
Xla Wt + rspo2 MO - right
NF19 (in situ hybridization)
|
|
visceral heterotaxy
|
|
Fig. 2. E F
Deniz E et al. (2023)
|
Xtr Wt + cfap45 CRISPR
NF18 (in situ hybridization)
|
|
|
|
|
Fig. 2. E F
Deniz E et al. (2023)
|
Xtr Wt + cfap45 CRISPR 2
NF18 (in situ hybridization)
|
|
|
|
Fig. S1 i r1_c2, j
Sempou E et al. (2022)
|
Xtr Wt + kcnh6 CRISPR (400pg)
NF16 (in situ hybridization)
|
|
|
|
|
Fig. S1 i r2_c2, j
Sempou E et al. (2022)
|
Xtr Wt + kcnh6 CRISPR (400pg)
NF19 (in situ hybridization)
|
|
|
|
Fig. 2 K-R
Kreis J et al. (2022)
|
Xla Wt + rab7a MO
NF17 (in situ hybridization)
|
|
|
|
Fig. 3 C
Maerker M et al. (2021)
|
Xla Wt + bicc1
NF20 (in situ hybridization)
|
|
|